ACTSI Investigator Dr. Mark Goodman in the News

Mark Goodman, PhD, ACTSI investigator and professor of radiology, psychiatry and hematology and oncology, Emory University School of Medicine

Lab Land | FDA approves Emory-developed cancer imaging probe
June 6, 2016

Emory News Center | FDA Approves Emory-Developed Prostate Cancer Imaging Probe
June 1, 2016

Yahoo News | U.S. FDA approves Blue Earth Diagnostics’ Axumin(TM) (Fluciclovine F 18) injection after priority review for PET imaging of recurrent prostate cancer
May 31, 2016

Goodman won the Start-up of 2015 Award from Emory’s Office of Technology Transfer for Microbial Medical

Lab Land | Promising probe for detecting recurrent prostate cancer
June 18, 2015

Emory News Center | Mark Goodman, PhD, earns nuclear medicine imaging award
June 1, 2012

Goodman’s project, Development and Preclinical Testing of a “L” Large Neutral Amino Acid Imaging Biomarker for Systemic Tumors with High LAT Expression was funded by the Winship Cancer Institute CCSG Fund (McCarty Fund)

Upcoming Events

    View All Events

    Latest News

    Training

    Georgia CTSA at UGA: Henry Young, PhD Improving Medication Use & Enhancing Care Communication

    In 2013, Henry Young, PhD joined the University of Georgia (UGA) as the Kroger Associate Professor in Community Pharmacy. For the Georgia Clinical & Translational Science Alliance (Georgia CTSA) he is a co-director of the Integrating Special...